胰岛素促泌剂及其对胰岛β细胞功能的影响

被引：3

作者：

王庆美

季虹

荣海钦

机构：

[1] 山东省内分泌与代谢病研究所

来源：

医学综述 | 2009年 / 15卷 / 14期

关键词：

胰岛素促泌剂; β细胞; 胰岛;

D O I：

暂无

中图分类号：

R587.1 [糖尿病];

学科分类号：

100201 [内科学];

摘要：

胰岛素促泌剂是目前治疗2型糖尿病的一类主要口服降糖药,是非肥胖及部分肥胖2型糖尿病的一线治疗药物。近年来研究发现,2型糖尿病患者胰岛β细胞凋亡明显增加,二者之间的关系及2型糖尿病胰岛β细胞凋亡的机制逐渐成为人们关注的热点。由于它的治疗作用与胰岛β细胞的功能状态密切相关,本文就各种胰岛素促泌剂对胰岛β细胞功能的影响予以综述,为2型糖尿病的合理用药提供新思路。

引用

页码：2103 / 2105

页数：3

共 19 条

[1]

Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients [J].

Malaisse, Willy J. .

EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (15) :2691-2698

[2]

β-cell apoptosis in type 2 diabetes: quantitative and functional consequences.[J].R. Lupi;S. Del Prato.Diabetes and Metabolism.2008,

[3]

Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic β-cell line, MIN6 [J].

Sawada, Fumi ;

Inoguchi, Toyoshi ;

Tsubouchi, Hirotaka ;

Sasaki, Shuji ;

Fujii, Masakazu ;

Maeda, Yasutaka ;

Morinaga, Hidetaka ;

Nomura, Masatoshi ;

Kobayashi, Kunihisa ;

Takayanagi, Ryoichi .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (08) :1038-1045

[4]

Endoplasmic reticulum stress in beta cells: Latent mechanism of secondary sulfonylurea failure in type 2 diabetes? [J].

Qian, Lei ;

Zhang, Suhe ;

Xu, Lihong ;

Peng, Yongde .

MEDICAL HYPOTHESES, 2008, 71 (06) :889-891

[5]

New combination treatments in the management of diabetes: focus on sitagliptin – metformin.[J].Jennifer Green.Vascular Health and Risk Management.2008, Issu

[6]

Sulfonylurea and glinide reduce insulin content, functional expression of KATP channels, and accelerate apoptotic β-cell death in the chronic phase [J].

Takahashi, Akira ;

Nagashima, Kazuaki ;

Hamasaki, Akihiro ;

Kuwamura, Naomitsu ;

Kawasaki, Yukiko ;

Ikeda, Hiroki ;

Yamada, Yuichiro ;

Inagaki, Nobuya ;

Seino, Yutaka .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 77 (03) :343-350

[7]

Sulfonylurea induced β-cell apoptosis in cultured human islets [J].

Maedler, K ;

Carr, RD ;

Bosco, D ;

Zuellig, RA ;

Berney, T ;

Donath, MY .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :501-506

[8]

Insulinotropic meglitinide analogues [J].

Dornhorst, A .

LANCET, 2001, 358 (9294) :1709-1716

[9]

Repaglinide – a new compound for the treatment of patients with type 2 diabetes.[J].Bruce H.R Wolffenbuttel.Netherlands Journal of Medicine.1999, 5

[10]

Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action..Renstrom E;Barg S;Thevenod F;et al;.Diabetes; 2002.,

← 1 2 →